Letter to the editor re: Cabrera et al., 2019 'The antagonism of folate receptor by dolutegravir: developmental toxicity reduction by supplemental folic acid'.
| Autor: | Romach EH; ViiV Healthcare, RTP, North Carolina GlaxoSmithKline, Collegeville, Pennsylvania, USA., Stanislaus D, Zamek-Gliszczynski MJ |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | AIDS (London, England) [AIDS] 2020 Jan 01; Vol. 34 (1), pp. 162-163. |
| DOI: | 10.1097/QAD.0000000000002407 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|